Cancer Stemness Meets Immunity:From Mechanism To Therapy(Part 1)

Jun 09, 2022

To learn more info plz contact david.wan@wecistanche.com

Cancer stem cells (CSCs) are self-renewing cells that facilitate tumor initiation, promote metastasis, and enhance cancer therapy resistance. Transcriptomic analyses across many cancer types have revealed a prominent association between stemness and immune signatures, potentially implying a biological interaction between such hallmark features of cancer. Emerging experimental evidence has substantiated the influence of CSCs on immune cells, including tumor-associated macrophages, myeloid-derived suppressor cells, and T cells, in the tumor microenvironment and, reciprocally, the importance of such immune cells in sustaining CSC stemness and its survival niche. This review covers the cellular and molecular mechanisms underlying the symbiotic interactions between CSCs and immune cells and how such heterotypic signaling maintains a tumor-promoting ecosystem and informs therapeutic strategies intercepting this co-dependency.

bioflavonoids meaning

Click here to learn more about Cistanche

INTRODUCTION

The cancer stem cell(CSC) paradigm emerged from the study of acute myeloid leukemia (AML), which identified a subpopulation of less-differentiated CD34*/CD387 cells possessing stem-cell-like renewal capacity and robust tumor-initiating capacity (Lapi-dot et al,1994). Cancer cells with these biological properties have since been detected in virtually all solid tumors, including melanoma and cancers of the brain, breast, colon, thyroid, pancreas, prostate, liver, lung, ovary, head and neck, and stomach(Turdo et al,2019). The clinical and biological significance of CSCs has been reinforced by a positive correlation between stem cell signatures and poor survival (Ben-Porath et al, 2008). Although CSCs share properties and surface markers with normal stem cells (Turdo et al.,2019), they maintain renewal capacity via specific altered signaling pathways with common and unique patterns across many tumor types(Figure 1). For instance, breast cancer CSCs show CD44 standard splice iso-form (CD44s)-activated platelet-derived growth factor receptor β(PDGFRβ)/signal transducer and activator of transcription 3 (STAT3), forkhead box C1 (FOXC1)-activated sonic hedgehog (SHH), and sphingosine-1-phosphate (S1P)/S1PR3-activated NOTCH pathways (Han et al, 2015; Hirata et al,2014; Zhang et al,2019b).In contrast, CSC stemness in other cancer types, such as glioma and colon, gastric, and prostate cancers, is maintained via CD133-mediated phosphatidylinositol-3-kinase (Pl3K)/protein kinase B(AKT,leucine-rich G-protein-coupled receptor 5(LGR5)-mediated WNT/β-catenin and speckle-type POZ protein (SPOP)-mediated NANOG pathways (Morgan et al.,2018; Wang et al.,2010b,2019a; Wei et al.,2013; Zhang et al.,2019c). Such CSC-associated patterns belie a high degree of biological complexity and tumor type specificity.

1654742498578

The hallmark traits of CSCs are well established and include self-renewal, clonal tumor initiation capacity, clonal long-term re-population potential, and plasticity between stem and non-stem states (Plaks et al.,2015). This plasticity is particularly relevant because it enables CSCs to adapt and survive in the face of therapeutic perturbations as well as the ever-changing biological stresses of the tumor microenvironment (TME) throughout tumor evolution (Agliano et al.,2017; Hatina,2012; Müller et al.,2020; Plaks et al.,2015). Mechanistically, the role of CSCs in tumor initiation, metastasis, and therapy resistance has been shown to be driven by interactions between cancer cells and host cells in the TME (Ayob and Ramasamy,2018; Plaks et al,2015), where the molecules and pathways driving CSC biology often power multiple cancer hallmarks (Figure 1). For example, the tumor-initiating capacity of CSCs relates to their stemness driven by the transcription factor sex-determining region Y-box 2(SOX2), which also upregulates genes governing the cancer hallmarks of proliferation, survival, and invasion(Boumahdi et al.,2014; Zhou et al, 2009).In the case of the metastasis hallmark, stem cell signatures correlate positively with enhanced metastatic propensity(Ayob and Ramasamy,2018); moreover, diverse CSC pathways and associated biological processes contribute to each step of the metastatic process-from dissemination to metastatic niche formation to distant organ growth-by inducing epithelial-mesenchymal transition (EMT, stimulating exosome production from myeloid cells and upregulating niche-derived factors, such as insulin-like growth factor-1 (IGF-1) and interleukin (L)-6, respectively(Agliano et al.,2017; Ayob and Ramasamy,2018; Shiozawa et al,2013). Indeed, experimental and clinical evidence demonstrates that CSCs in primary tumors disseminate and colonize distal sites(de Sousae Melo et al.,2017)and that their location at the invasive front correlates negatively with patient survival (Kodamaet al.,2017). Finally, with respect to therapy resistance, CSC pathways alter signaling molecules governing drug metabolism(e.g., high expression of ATP-binding cassette transporter proteins that increase drug efflux rate), EMT (e.g., increased SOX2,octamer-binding transcription factor 4 [OCT4], and NANOG expression), and metabolic reprogramming (e.g., enhanced glucose transporter 1, oxidative phosphorylation, and reactive oxygen species activity; Ayob and Ramasamy,2018). The phenotypic plasticity of CSCs can contribute to additional cancer hallmarks via their capacity to transdifferentiate into peri-cytes, endothelial cells, and fibroblasts, thus contributing to tumor angiogenesis, stem cell niche development, and inflammation (Figure 1; Cheng et al,2013; Dongre and Weinberg, 2019; Huet al.,2016; Nair et al.,2017; Ricci-Vitiani et al.,2010; Wang et al.,2010a). This plasticity is also reflected in the capacity of "differentiated" cancer cells to re-adopt an immature CSC state, a dedifferentiation process that can be stimulated by signals emanating from the TME, including tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), T-cells, cancer-associated fibroblasts (CAFs), and other immune cells(Plaks et al.,2015). Most notably, the strong CSC-immune cell connection was evidenced by unbiased profiling studies, showing a strong negative correlation between cancer cell stem-ness and anti-tumor immunity signatures across 21 types of solid tumors (Miranda et al,2019). Specifically, increased stem-ness was associated with reduced anti-cancer immune cells, including CD8+ T cells, natural killer (NK) cells, and B cells, and enhanced polarization of infiltrating macrophages(Miranda et al,2019). Similarly, the cancer genome atlas(TCGA) and tissue microarray analyses have revealed that cancer cell stem-ness correlates negatively with activated CD4+ and CD8+Tcells in solid tumors(Hou et al.,2019; Malta et al,2018).

cistache

These in silico findings in human cancer align well with emerging experimental findings from studies of various mouse models of human cancer. It has been shown that the proportion of CSCs in melanoma is dependent on the specific immune-compromised mouse strain employed, suggesting an important role of the immune system in the regulation of CSCs (Quintana et al.,2008). On the other hand, CSCs can shape a specific TME by their regulation of immune cells. For instance, the expression of CSC marker and regulator doublecortin-like kinase 1 (Westphalen et al.,2014) correlates positively with an abundance of TAMs and regulatory T cells (T-reg cells) and elevated expression of factors that inhibit CD8+ Tcell activity (Wu et al,2020). CKLF-like MARVEL transmembrane-domain-containing 6, which is expressed on cancer cell plasma membranes, can enhance CSC stemness via the WNT/β-catenin pathway, suppress anti-tumor immunity via programmed death-ligand 1 (PD-L1)upregulation, and reduce CD8* and CD4* T cells in many types of cancer, including squamous cell carcinoma of the head and neck (SCCHN)(Chen et al.,2020a), melanoma, and breast cancer (Burr et al,2017; Mezzadraet al,2017). Fat-mass-and obesity-associated protein (FTO) is a m°A demethylase and overexpressed in AML. Inhibition of FTO impairs leukemia stem cell stemness and reprograms immune response by suppressing immune checkpoint genes, such asLILRB4 (leukocyte immunoglobulin-like receptor subfamily B member 4), thus sensitizing AML cells to T-cell-mediated cytotoxicity(Suet al,2020). Similarly,single-cell RNA sequencing (RNA-seq) analyses of AML revealed a subpopulation of stem-like AML cells that co-express stemness-related and myeloid-priming genes (van Galen et al,2019). In addition, CSC-derived exosomes, which transfer cargo between cells(Mathieu et al, 2019), can enhance the survival of suppressive neutrophils to promote colon cancer growth(Hwang et al,2019). This shared stem-ness and immune transcriptional profile align with the recent finding that the lack of natural killer group 2 member Dligands, which defines leukemia stem cells, contributes to their selective escape from NK-cell-mediated immune surveillance (Paczulla et al., 2019).In addition to these immune cells, CAFs and their interactions with CSCs are also important for tumorigenesis and therapy resistance (Chan et al,2019). Together, these findings highlight an intimate link between the molecules and mechanisms governing CSC biology and tumor immunity across many tumor types.

In summary, mounting translational and experimental evidence underscores the myriad interactions and intertwined tumor biological roles of CSCs and immune cells, particularly myeloid cells (TAMs and MDSCs)and T cells. This review summarizes the current knowledge of the molecular crosstalk and the functional impact of these symbiotic interactions on the hall-marks of cancer. With respect to myeloid cells, we highlight TAM and MDSC individually, although they share the same cell of origin and similar functions to suppress T-cell-mediated anti-tumor immunity (Engblom et al., 2016). These emerging insights provide a roadmap for the development of novel anti-cancer therapeutic strategies that disrupt this dynamic circuit in specific tumor types.

1654742568765

1654742602942

CSC-TAM Crosstalk

Impact of CSCs on Macrophage Biology

Factors secreted by various cell types in the TME, including CSCs, are known to recruit and polarize TAMs (Chen et al.,2017,2019a,2020b; Colegio et al,2014). These TAMs are sourced from bone-marrow-derived macrophages (BMDMs)and local tissue-resident macrophages (e.g., microglia in the brain, Kupffer cells in the liver, and alveolar macrophages in the lung), which originate from hematopoietic stem cells and progenitors seeding in embryonic tissues (e.g., the yolk sac for microglia and the fetal liver for Kupffer cells and alveolar macrophages), respectively (Figure 2; Pathriaet al.,2019).TAM recruitment is driven by a variety of chemokines, including C-C motif chemokine ligand 2(CCL2), CCL3, C-X-C motif chemokine ligand 14(CXCL14), and lysyl oxidase(LOX), which are secreted by cancer cells, macrophages, and other stromal cells in the TME (Chen et al.,2019a; Pathria et al.,2019; Wei et al.,2020. Increasing evidence shows that CSCs also contribute to the infiltration of macrophages and microglia via distinct molecules and mechanisms in various cancers (Figure 2; Table 1). Of note, some of these chemokines are specifically produced by CSCs, which highlights a unique role of CSCs in the regulation of TAM infiltration. For example, periostin (POSTN) is preferentially expressed and secreted by CSCs in glioblastoma (GBM) and cholangiocarcinoma (CCA), which in turn recruits BMDMs through binding with xvB3 integrin (Zeng et al,2018; Zhou et al.,2015).

cistanche amway

Genetic and epigenetic changes in CSCs regulate chemokine production. For example, PTENdeficiencyor AKToverexpression in GSCs and neural stem cells upregulates LOX and CXCL12B, which recruits TAMs through β1 integrin (Chen et al.,2019a) and C-X-C motif chemokine receptor 4(CXCR4) (Chia et al.,2018), respectively. Optic GSCs isolated from the Nf1loxneo; GFAP-Cre low-grade glioma mouse model secrete CX3CL1 and CCL5 to recruit microglia, and this effect is further amplified by the loss of Pten (Guo et al,2019b). Similarly, F1 deficiency in human GSCs can promote the infiltration of macrophages and microglia, although the NF1-regulated chemokines are not known (Wang et al,2017).In many tumor types, epidermal growth factor receptor (EGFR) amplification and mutation can promote CSC stem-ness and macrophage recruitment (An et al,2018; McCann et al,2018; Rutkowska et al,2019). In liver cancer, EGFR/AKT activation activates the yes-associated protein(YAP)/TEA domain family member (TEAD) transcription factor complex in CSCs, which in turn upregulates macrophage recruitment factors CCL2 and macrophage colony-stimulating factor (M-CSF) (Guo et al。2017). In non-small cell lung cancer (NSCLC), increased ubiquitin-specific protease 17, a deubiquitinase required for trafficking and oncogenic activity of mutant EGFR(McCann et al.,2018), increases cancer cell stemness, which in turn upregulates macrophage infiltration by augmented production of cytokines, including tumor necrosis factor (TNF)-a, IL-1β, and IL-6 (Lu et al.,2018). In bladder cancer, loss-of-function mutations of the histone modifier gene lysine (K)-specific demethylase 6A (KDM6A) promote CSC stemness and secretion of IL-6 and CCL2, which in turn increase macrophage recruitment (Kobatake et al., 2020). In GBM, circadian locomotor output cycles kaput (CLOCK), an epigenetic and circadian regulator amplified in 5%of cases, enhances GSC stemness and secretion of the chemo-kine olfactomedin-like protein 3 (OLFML3), which recruits microglia into the TME (Chen et al., 2020b). Finally, caveat emptor, although many studies have established the involvement of CSC-derived factors in macrophage infiltration, the converse has also been observed due to the specific CSC genotype and its unique TME. For example, TP53-mutated and cisplatin-resistant CSCs from lung cancer inhibits macrophage infiltration into the TME (Xu et al.,2019).

cistanche beneficios

1654743092356

In addition to stimulating TAM recruitment, CSCs can influence the biological state of these macrophages. Macrophages are known to exhibit a spectrum of phenotypes, ranging from an anti-tumor to pro-tumor phenotype (formerly referred to as M1 and M2; Pathria et al., 2019). Once macrophages infiltrate into tumors, they typically undergo polarization toward a pro-tumor phenotype, a process driven by chemokines (e.g., IL-4 and IL-13) and metabolites (e.g., lactate), which are derived from both cancer cells and host cells in the TME (Chen et al., 2017; Colegio et al.,2014; Qian and Pollard,2010). Several lines of evidence demonstrate that CSCs can further provoke anti- to protumor polarization of macrophages. First, upon co-culture with CSCs, pro-tumor macrophage markers (e.g., CD206, IL-10, and arginase 1) are upregulated, whereas anti-tumor macrophage markers (e.g., TNF-α, nitric oxide synthase 2 [NOS2], and CD86) are downregulated (Deng et al,2015). Second, CSCs can secrete various soluble factors that induce polarization toward a pro-tumor phenotype (Figure 2; Table 1). For example, Wnt-induced signaling protein 1(WSP1) is preferred-tally secreted by GSCs in GBM, which promotes the survival of pro-tumor TAMs through activation of the x6β1 integrin/AKT pathway on macrophages(Tao et al,2020). Similarly, CSC-derived IL-6 and IL-10 can skew TAMs toward a pro-tumor phenotype in ovarian cancer(Raghavan et al,2019), bladder cancer(Kobatake et al,2020), GBM (Wu et al,2010; Yao et al.,2016), and breast cancer(Weng et al,2019).In addition to secreted factors, GSCs release exosomes containing eukaryotic initiation factor 2, mammalian target of rapamycin (mTOR), and ephrin B signaling pathways that are home to the monocyte membrane and promote macrophage pro-tumor polarization (Gabrusiewiczet al,2018). Finally, in the context of tumor necrosis in GBM, GSC-derived particles, defined as"autoschizis-like products," can be engulfed by TAMs, which in turn upregulate L-12 to polarize these TAMs toward an anti-tumor phenotype (Tabu et al,2020). Thus, CSCs secrete a variety of products that encourage macrophage polarization.







You Might Also Like